335 related articles for article (PubMed ID: 30942794)
1. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.
Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794
[TBL] [Abstract][Full Text] [Related]
2. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells.
Kumar P; Mondal I; Kulshreshtha R; Patra AK
Dalton Trans; 2020 Oct; 49(38):13294-13310. PubMed ID: 32936191
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
[TBL] [Abstract][Full Text] [Related]
4. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
5. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.
Wang N; Ali A; Liu Z; Chi H; Lv Z; Zhao X; Zhang Z; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2023 Oct; 258():115536. PubMed ID: 37295260
[TBL] [Abstract][Full Text] [Related]
6. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
7. DNA targeting half sandwich Ru(II)-
Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P
Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328
[TBL] [Abstract][Full Text] [Related]
8. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
[TBL] [Abstract][Full Text] [Related]
9. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
11.
Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
[TBL] [Abstract][Full Text] [Related]
13. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
[TBL] [Abstract][Full Text] [Related]
15. Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging.
Mondal A; De S; Maiti S; Sarkar B; Sk AK; Jacob R; Moorthy A; Paira P
J Photochem Photobiol B; 2018 Jan; 178():380-394. PubMed ID: 29195215
[TBL] [Abstract][Full Text] [Related]
16. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
17. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
Bhattacharyya S; Purkait K; Mukherjee A
Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
[TBL] [Abstract][Full Text] [Related]
19. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
[TBL] [Abstract][Full Text] [Related]
20. Novel pyrazolylphosphite- and pyrazolylphosphinite-ruthenium(ii) complexes as catalysts for hydrogenation of acetophenone.
Amenuvor G; Obuah C; Nordlander E; Darkwa J
Dalton Trans; 2016 Sep; 45(34):13514-24. PubMed ID: 27504937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
